Details of Drug

Drug General Information (ID: D0627)
Drug Name	Etoposide
Drug Type	Small molecule
Drug Synonymous	etoposide; 33419-42-0; VePesid; Toposar; trans-Etoposide; Lastet; (-)-Etoposide; Zuyeyidal; Etoposidum; Etoposido; Vepesid J; Eposin; Etoposidum [INN-Latin]; Etoposide (VP16); VP 16-213; VP 16 (pharmaceutical); Etoposido [INN-Spanish]; Etopophos (phosphate salt); VP-16-213; 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside; VP 16213; UNII-6PLQ3CP4P3; NK 171; NSC 141540; CCRIS 2392; HSDB 6517; 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside); EINECS 251-509-1; NSC-141540; Eposide; Etopol; Etosid; Vepeside; Demethyl EpipodophyllotoxinEthylidine Glucoside; E0675; Demethyl-epiodophyllotoxin ethylidene glucoside; Epipodophyllotoxin VP-16213; Eposin (TN); Etopophos (TN); Trans-Etoposide; VePESID (TN); Vepesid (TN); DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE; VP-16 (TN); Demethylepipodophyllotoxin-beta-D-ethylideneglucoside; Etoposide (JP15/USP/INN); Etoposide [USAN:INN:BAN:JAN]; Eposin, Vepesid, VP-16, Toposar, Etoposide; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI); Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside); 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside; 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside); 4'-Demethylepipodophyllotoxin ethylidene-beta-D-glucoside; 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin; 4-Demethylepipodophyllotoxin-beta-D-ethylideneglucoside Click to Show/Hide
Disease Class	2A00-2F9Z: Solid tumour/cancer
Therapeutic Class	Antineoplastics
Structure
Structure	3D Structure		2D Structure
Formula	C29H32O13
InChI	1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1
InChIKey	VJJPUSNTGOMMGY-MRVIYFEKSA-N
Canonical SMILES	CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
External Link
	Pubchem ID	36462
	CAS Number	33419-42-0
	CHEBI ID	4911
	TTD ID	D0B7EB
	INTEDE ID	DR0669
	VARIDT ID	DR00162

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM002 Affected cellular transport AM003 Affected organization distribution AM004 Affected intra/extra-hepatic metabolism AM005 Affected excretion pathways AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM006 Altered intestinal mucosa BM010 Transporter inhibition BM011 Transporter induction BM012 Competitive inhibition of transporters BM013 Competitive binding of plasma proteins BM017 CYP450 enzyme inhibition BM022 CYP450 enzyme induction BM024 Competitive inhibition of metabolic enzyme BM031 Increased renal excretion (Unspecific) BM043 Additive immunosuppressive effects BM044 Additive myelosuppressive effects BM047 Additive thrombogenic effects BM074 Increased risk of peripheral neuropathy BM100 Antagonize the effect of vaccine/toxoid BM105 Antagonize the effect of probiotics BM106 Diminish the response to diagnostic skin test antigens BM107 Attenuated pharmacological effects (Unspecific)
Relation Graph

Full list of drugs interacting with Etoposide
Affected gastrointestinal absorption
	Altered intestinal mucosa					Drug Num: 14
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0341		Ciprofloxacin	C17H18FN3O3	2764	Minor		Inter Info	[244]
D0573		Enoxacin	C15H17FN4O3	3229	Minor		Inter Info	[244]
D0340		Cinoxacin	C12H10N2O5	2762	Minor		Inter Info	[244]
D0438		Delafloxacin	C18H12ClF3N4O4	487101	Minor		Inter Info	[244]
D0712		Gatifloxacin	C19H22FN3O4	5379	Minor		Inter Info	[244]
D0716		Gemifloxacin	C18H20FN5O4	9571107	Minor		Inter Info	[244]
D0919		Levofloxacin	C18H20FN3O4	149096	Minor		Inter Info	[244]
D0943		Lomefloxacin	C17H19F2N3O3	3948	Minor		Inter Info	[244]
D1102		Nalidixic acid	C12H12N2O3	4421	Minor		Inter Info	[244]
D1155		Norfloxacin	C16H18FN3O3	4539	Minor		Inter Info	[244]
D1165		Ofloxacin	C18H20FN3O4	4583	Minor		Inter Info	[244]
D1499		Sparfloxacin	C19H22F2N4O3	60464	Minor		Inter Info	[244]
D1092		Moxifloxacin	C21H24FN3O4	152946	Minor		Inter Info	[244]
D1657		Trovafloxacin	C20H15F3N4O3	62959	Minor		Inter Info	[244]
Affected cellular transport
	Transporter inhibition					Drug Num: 13
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0402		Cyclosporine	C62H111N11O12	5284373	Moderate		Inter Info	[76], [77]
D0044		Alpelisib	C19H22F3N5O2S	56649450	Moderate		Inter Info	[7], [89], [90]
D0251		Capmatinib	C23H17FN6O	25145656	Moderate		Inter Info	[104]
D0408		Daclatasvir	C40H50N8O6	25154714	Moderate		Inter Info	[7], [109]
D0569		Encorafenib	C22H27ClFN7O4S	50922675	Moderate		Inter Info	[7], [120]
D0590		Erdafitinib	C25H30N6O2	67462786	Moderate		Inter Info	[123]
D0720		Gilteritinib	C29H44N8O3	49803313	Moderate		Inter Info	[14], [7], [131]
D0725		Glasdegib	C21H22N6O	25166913	Moderate		Inter Info	[7], [132]
D0897		Lasmiditan	C19H18F3N3O2	11610526	Moderate		Inter Info	[146]
D0898		Ledipasvir	C49H54F2N8O6	67505836	Moderate		Inter Info	[147]
D1062		Midostaurin	C35H30N4O4	9829523	Moderate		Inter Info	[7]
D1423		Rolapitant	C25H26F6N2O2	10311306	Moderate		Inter Info	[180]
D1608		Tolvaptan	C26H25ClN2O3	216237	Moderate		Inter Info	[14], [7], [199], [200]
	Transporter induction					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0095		Apalutamide	C21H15F4N5O2S	24872560	Moderate		Inter Info	[7], [93]
	Competitive inhibition of transporters					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1791		Gadobenic acid	C22H28GdN3O11	9852779	Moderate		Inter Info	[229], [230]
Affected organization distribution
	Competitive binding of plasma proteins					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0481		Dicoumarol	C19H12O6	54676038	Moderate		Inter Info	[78], [79], [80]
D0087		Anisindione	C16H12O3	2197	Moderate		Inter Info	[79], [80]
D1711		Warfarin	C19H16O4	54678486	Moderate		Inter Info	[79], [80]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 47
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0100		Aprepitant	C23H21F7N4O3	135413536	Moderate		Inter Info	[54], [55], [56], [57], [58], [59]
D0497		Diltiazem	C22H26N2O4S	39186	Moderate		Inter Info	[81], [82], [83], [84], [85]
D0002		Abametapir (topical)	C12H12N2	15664	Moderate		Inter Info	[88]
D0192		Boceprevir	C27H45N5O5	10324367	Moderate		Inter Info	[97]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Moderate		Inter Info	[7], [106]
D0386		Conivaptan	C32H26N4O2	151171	Moderate		Inter Info	[107]
D0413		Dalfopristin	C34H50N4O9S	6323289	Moderate		Inter Info	[110]
D0426		Darunavir	C27H37N3O7S	213039	Moderate		Inter Info	[111]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Moderate		Inter Info	[112]
D0432		Deferasirox	C21H15N3O4	214348	Moderate		Inter Info	[113], [114]
D0534		Dronedarone	C31H44N2O5S	208898	Moderate		Inter Info	[117]
D0543		Duvelisib	C22H17ClN6O	50905713	Moderate		Inter Info	[118]
D0638		Fedratinib	C27H36N6O3S	16722836	Moderate		Inter Info	[7], [125]
D0693		Fosaprepitant	C23H22F7N4O6P	135413538	Moderate		Inter Info	[54], [55], [56], [57], [58], [59]
D0699		Fostamatinib	C23H26FN6O9P	11671467	Moderate		Inter Info	[128]
D0789		Idelalisib	C22H18FN7O	11625818	Moderate		Inter Info	[133]
D0852		Isavuconazonium	C35H35F2N8O5S+	6918606	Moderate		Inter Info	[7], [134]
D0867		Itraconazole	C35H38Cl2N8O4	55283	Moderate		Inter Info	[135], [14], [136], [137], [138], [139], [140], [141], [142]
D0869		Ivacaftor	C24H28N2O3	16220172	Moderate		Inter Info	[143]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Moderate		Inter Info	[144]
D0896		Larotrectinib	C21H22F2N6O2	46188928	Moderate		Inter Info	[14], [7], [145]
D0899		Lefamulin	C28H45NO5S	25185057	Moderate		Inter Info	[148]
D0906		Letermovir	C29H28F4N4O4	45138674	Moderate		Inter Info	[149]
D0946		Lonafarnib	C27H31Br2ClN4O2	148195	Moderate		Inter Info	[150]
D1063		Mifepristone	C29H35NO2	55245	Moderate		Inter Info	[14], [7], [152], [153]
D1117		Nefazodone	C25H32ClN5O2	4449	Moderate		Inter Info	[154]
D1136		Nilotinib	C28H22F3N7O	644241	Moderate		Inter Info	[155]
D1315		Posaconazole	C37H42F2N8O4	468595	Moderate		Inter Info	[7]
D1398		Ribociclib	C23H30N8O	44631912	Moderate		Inter Info	[169], [170], [171], [172], [173], [174], [175], [176], [59]
D1432		Rucaparib	C19H18FN3O	9931954	Moderate		Inter Info	[181]
D1444		Saquinavir	C38H50N6O5	441243	Moderate		Inter Info	[183], [184]
D1459		Selpercatinib	C29H31N7O3	134436906	Moderate		Inter Info	[7], [185]
D1505		Stiripentol	C14H18O3	5311454	Moderate		Inter Info	[63]
D1541		Telaprevir	C36H53N7O6	3010818	Moderate		Inter Info	[195]
D1544		Telithromycin	C43H65N5O10	3002190	Moderate		Inter Info	[196], [197]
D1660		Tucatinib	C26H24N8O2	51039094	Moderate		Inter Info	[202]
D1709		Voxelotor	C19H19N3O3	71602803	Moderate		Inter Info	[204]
D0667		Fluconazole	C13H12F2N6O	3365	Moderate		Inter Info	[209], [210], [211], [212], [213], [214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226]
D0687		Fluvoxamine	C15H21F3N2O2	5324346	Moderate		Inter Info	[227], [228]
D0740		Grepafloxacin	C19H22FN3O3	72474	Moderate		Inter Info	[231]
D0793		Imatinib	C29H31N7O	5291	Moderate		Inter Info	[232]
D1119		Nelfinavir	C32H45N3O4S	64143	Moderate		Inter Info	[234]
D1415		Ritonavir	C37H48N6O5S2	392622	Moderate		Inter Info	[240], [241], [187]
D1706		Voriconazole	C16H14F3N5O	71616	Moderate		Inter Info	[14], [7], [242]
D0439		Delavirdine	C22H28N6O3S	5625	Minor		Inter Info	[245], [246], [247], [248], [249], [250]
D1697		Vinblastine	C46H58N4O9	13342	Minor		Inter Info	[258]
D1698		Vincristine	C46H56N4O10	5978	Minor		Inter Info	[259], [258]
	CYP450 enzyme induction					Drug Num: 28
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0178		Bexarotene	C24H28O2	82146	Moderate		Inter Info	[7], [60], [61]
D0194		Bosentan	C27H29N5O6S	104865	Moderate		Inter Info	[71]
D0255		Carbamazepine	C15H12N2O	2554	Moderate		Inter Info	[72], [73]
D0554		Efavirenz	C14H9ClF3NO2	64139	Moderate		Inter Info	[87]
D0204		Brigatinib	C29H39ClN7O2P	68165256	Moderate		Inter Info	[100]
D0300		Cenobamate	C10H10ClN5O2	11962412	Moderate		Inter Info	[105]
D0406		Dabrafenib	C23H20F3N5O2S2	44462760	Moderate		Inter Info	[7], [108]
D0545		Echinacea	NA	NA	Moderate		Inter Info	[14], [119]
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Moderate		Inter Info	[121], [14], [7], [122]
D0628		Etravirine	C20H15BrN6O	193962	Moderate		Inter Info	[124]
D0697		Fosphenytoin	C16H15N2O6P	56339	Moderate		Inter Info	[72], [73]
D0953		Lorlatinib	C21H19FN6O2	71731823	Moderate		Inter Info	[151]
D1198		Oxcarbazepine	C15H12N2O2	34312	Moderate		Inter Info	[72], [73]
D1265		Phenobarbital	C12H12N2O3	4763	Moderate		Inter Info	[72], [73]
D1302		Pitolisant	C17H26ClNO	9948102	Moderate		Inter Info	[7], [167]
D1340		Primidone	C12H14N2O2	4909	Moderate		Inter Info	[72], [73]
D1401		Rifapentine	C47H64N4O12	135403821	Moderate		Inter Info	[177], [178]
D1433		Rufinamide	C10H8F2N4O	129228	Moderate		Inter Info	[7], [182]
D1493		Somapacitan	C54H95N13O20S2	129894493	Moderate		Inter Info	[14], [7], [189]
D1495		Somatrem	C43H72N14O14	5487805	Moderate		Inter Info	[14], [7], [190], [189]
D1502		St. John's Wort	NA	NA	Moderate		Inter Info	[191], [192]
D1538		Tazemetostat	C34H44N4O4	66558664	Moderate		Inter Info	[194]
D1546		Telotristat ethyl	C27H26ClF3N6O3	25181577	Moderate		Inter Info	[7], [198]
D1128		Nevirapine	C15H14N4O	4463	Moderate		Inter Info	[14], [7], [235], [236]
D1283		Phenytoin	C15H12N2O2	1775	Moderate		Inter Info	[72], [73]
D1494		Somatotropin	NA	NA	Moderate		Inter Info	[14], [7], [189]
D0106		Armodafinil	C15H15NO2S	9690109	Minor		Inter Info	[251], [252], [253], [254], [255]
D1081		Modafinil	C15H15NO2S	4236	Minor		Inter Info	[251], [252], [253], [254], [255]
	Competitive inhibition of metabolic enzyme					Drug Num: 5
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0696		Fosnetupitant	C31H35F6N4O5P	71544786	Moderate		Inter Info	[14], [126], [127]
D1127		Netupitant	C30H32F6N4O	6451149	Moderate		Inter Info	[14], [126], [127]
D1476		Sirolimus	C51H79NO13	5284616	Moderate		Inter Info	[186], [187]
D1526		Tacrolimus	C44H69NO12	445643	Moderate		Inter Info	[186], [187]
D1549		Temsirolimus	C56H87NO16	6918289	Moderate		Inter Info	[186], [187]
Affected excretion pathways
	Increased renal excretion (Unspecific)					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0528		Doxorubicin	C27H29NO11	31703	Minor		Inter Info	[256]
D0529		Doxorubicin (liposomal)	C27H29NO11	31703	Minor		Inter Info	[256]
Pharmacodynamic additive effects
	Additive immunosuppressive effects					Drug Num: 76
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0023		Adalimumab	NA	NA	Major		Inter Info	[1], [2], [3], [4], [5], [6]
D0348		Cladribine	C10H12ClN5O3	20279	Major		Inter Info	[7], [8]
D0614		Etanercept	NA	NA	Major		Inter Info	[1], [2], [3], [4], [5], [6]
D0146		Baricitinib	C16H17N7O2S	44205240	Major		Inter Info	[14], [7], [15]
D0304		Certolizumab pegol	NA	NA	Major		Inter Info	[1], [5], [6]
D0661		Fingolimod	C19H33NO2	107970	Major		Inter Info	[18]
D0736		Golimumab	NA	NA	Major		Inter Info	[1], [2], [3], [4], [5], [6]
D0900		Leflunomide	C12H9F3N2O2	3899	Major		Inter Info	[19], [20]
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[7], [21]
D1474		Siponimod	C29H35F3N2O3	44599207	Major		Inter Info	[14], [23]
D1556		Teriflunomide	C12H9F3N2O2	54684141	Major		Inter Info	[19], [20]
D1600		Tofacitinib	C16H20N6O	9926791	Major		Inter Info	[43]
D1666		Upadacitinib	C17H19F3N6O	58557659	Major		Inter Info	[44]
D0802		Infliximab	NA	NA	Major		Inter Info	[1], [2], [3], [4], [5], [6]
D1111		Natalizumab	NA	NA	Major		Inter Info	[45]
D0030		Aldesleukin	NA	NA	Moderate		Inter Info	[7], [46], [47]
D0032		Alefacept	NA	NA	Moderate		Inter Info	[24], [48], [49]
D0033		Alemtuzumab	NA	NA	Moderate		Inter Info	[50]
D0085		Anakinra	C20H23N5O7S2	146171046	Moderate		Inter Info	[51], [52], [53]
D0190		Bleomycin	C55H84N17O21S3+	5360373	Moderate		Inter Info	[62], [14], [7], [63], [64], [47], [65], [66], [67]
D0264		Carmustine	C5H9Cl2N3O2	2578	Moderate		Inter Info	[7], [46], [47]
D0312		Chlorambucil	C14H19Cl2NO2	2708	Moderate		Inter Info	[7], [46], [47]
D0357		Clofarabine	C10H11ClFN5O3	119182	Moderate		Inter Info	[7], [46], [47]
D0400		Cyclophosphamide	C7H15Cl2N2O2P	2907	Moderate		Inter Info	[7], [46], [47]
D0429		Daunorubicin	C27H29NO10	30323	Moderate		Inter Info	[7], [46], [47]
D0430		Daunorubicin (liposomal)	C27H29NO10	30323	Moderate		Inter Info	[7], [46], [47]
D0553		Efalizumab	NA	NA	Moderate		Inter Info	[86]
D0584		Epirubicin	C27H29NO11	41867	Moderate		Inter Info	[7], [46], [47]
D0136		Azathioprine	C9H7N7O2S	2265	Moderate		Inter Info	[14], [7]
D0157		Bendamustine	C16H21Cl2N3O2	65628	Moderate		Inter Info	[7], [46], [47]
D0223		Busulfan	C6H14O6S2	2478	Moderate		Inter Info	[7], [46], [47]
D0246		Canakinumab	NA	NA	Moderate		Inter Info	[51], [52], [53]
D0249		Capecitabine	C15H22FN3O6	60953	Moderate		Inter Info	[7], [46], [47]
D0404		Cytarabine	C9H13N3O5	6253	Moderate		Inter Info	[7], [46], [47]
D0405		Cytarabine (liposomal)	C9H13N3O5	6253	Moderate		Inter Info	[7], [46], [47]
D0407		Dacarbazine	C6H10N6O	135398738	Moderate		Inter Info	[7], [46], [47]
D0410		Dactinomycin	C62H86N12O16	457193	Moderate		Inter Info	[7], [46], [47]
D0431		Decitabine	C8H12N4O4	451668	Moderate		Inter Info	[7], [46], [47]
D0443		Denosumab	NA	NA	Moderate		Inter Info	[115]
D0499		Dimethyl fumarate	C6H8O4	637568	Moderate		Inter Info	[116]
D0507		Diroximel fumarate	C11H13NO6	73330464	Moderate		Inter Info	[116]
D0780		Hydroxyurea	CH4N2O2	3657	Moderate		Inter Info	[7], [46], [47]
D0788		Idarubicin	C26H27NO9	42890	Moderate		Inter Info	[7], [46], [47]
D0851		Isatuximab	NA	NA	Moderate		Inter Info	[7], [46], [47]
D0945		Lomustine	C9H16ClN3O2	3950	Moderate		Inter Info	[7], [46], [47]
D0962		Lurbinectedin	C41H44N4O10S	57327016	Moderate		Inter Info	[7], [46], [47]
D0986		Mechlorethamine	C5H11Cl2N	4033	Moderate		Inter Info	[7], [46], [47]
D0996		Melphalan	C13H18Cl2N2O2	460612	Moderate		Inter Info	[7], [46], [47]
D1007		Mercaptopurine	C5H4N4S	667490	Moderate		Inter Info	[7], [46], [47]
D1079		Mitoxantrone	C22H28N4O6	4212	Moderate		Inter Info	[7], [46], [47]
D1085		Monomethyl fumarate	C5H6O4	5369209	Moderate		Inter Info	[116]
D1140		Niraparib	C19H20N4O	24958200	Moderate		Inter Info	[156]
D1162		Ocrelizumab	NA	NA	Moderate		Inter Info	[157]
D1167		Olaparib	C24H23FN4O3	23725625	Moderate		Inter Info	[7], [158]
D1174		Omacetaxine mepesuccinate	C29H39NO9	285033	Moderate		Inter Info	[159]
D1375		Radium Ra 223 dichloride	NA	NA	Moderate		Inter Info	[168]
D1403		Rilonacept	NA	NA	Moderate		Inter Info	[51], [52], [53]
D1422		Roflumilast	C17H14Cl2F2N2O3	449193	Moderate		Inter Info	[7], [179]
D1434		Ruxolitinib	C17H18N6	25126798	Moderate		Inter Info	[7], [46], [47]
D1487		Sodium phosphate, monobasic (p32)	NA	NA	Moderate		Inter Info	[188]
D1509		Strontium chloride Sr-89	Cl2Sr	5388879	Moderate		Inter Info	[14], [7], [193]
D1548		Temozolomide	C6H6N6O2	5394	Moderate		Inter Info	[7], [46], [47]
D1575		Thiotepa	C6H12N3PS	5453	Moderate		Inter Info	[7], [46], [47]
D1610		Topotecan	C23H23N3O5	60700	Moderate		Inter Info	[201]
D1671		Ustekinumab	NA	NA	Moderate		Inter Info	[203]
D0666		Floxuridine	C9H11FN2O5	5790	Moderate		Inter Info	[7], [46], [47]
D0675		Fluorouracil	C4H3FN2O2	3385	Moderate		Inter Info	[7], [46], [47]
D1025		Methotrexate	C20H22N8O5	126941	Moderate		Inter Info	[7], [46], [47]
D1077		Mitomycin	C15H18N4O5	5746	Moderate		Inter Info	[7], [46], [47]
D1855		Palifermin	NA	NA	Moderate		Inter Info	[237]
D1241		Pemetrexed	C20H21N5O6	135410875	Moderate		Inter Info	[7], [46], [47]
D1250		Pentostatin	C11H16N4O4	439693	Moderate		Inter Info	[7], [46], [47]
D1508		Streptozocin	C8H15N3O7	29327	Moderate		Inter Info	[7], [46], [47]
D1589		Tioguanine	C5H5N5S	2723601	Moderate		Inter Info	[7], [46], [47]
D1720		Zidovudine	C10H13N5O4	35370	Moderate		Inter Info	[14], [7], [243]
D0714		Gemcitabine	C9H11F2N3O4	60750	Minor		Inter Info	[257]
	Additive myelosuppressive effects					Drug Num: 5
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0370		Clozapine	C18H19ClN4	135398737	Major		Inter Info	[7], [9], [10]
D0433		Deferiprone	C7H9NO2	2972	Major		Inter Info	[14], [16], [17]
D1443		Samarium (153Sm) lexidronam	Sm	23951	Major		Inter Info	[22]
D0710		Ganciclovir	C9H13N5O4	135398740	Moderate		Inter Info	[14], [7], [129], [130]
D1676		Valganciclovir	C14H22N6O5	135413535	Moderate		Inter Info	[14], [7], [129], [130]
	Additive thrombogenic effects					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1569		Thalidomide	C13H10N2O4	5426	Major		Inter Info	[27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42]
	Increased risk of peripheral neuropathy					Drug Num: 68
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0193		Bortezomib	C19H25BN4O4	387447	Moderate		Inter Info	[68], [69], [70]
D0303		Cerivastatin	C26H34FNO5	446156	Moderate		Inter Info	[74], [46], [75]
D0313		Chloramphenicol	C11H12Cl2N2O5	5959	Moderate		Inter Info	[74], [46], [75]
D0320		Chloroquine	C18H26ClN3	2719	Moderate		Inter Info	[74], [46], [75]
D0419		Dapsone	C12H12N2O2S	2955	Moderate		Inter Info	[74], [46], [75]
D0616		Ethambutol	C10H24N2O2	14052	Moderate		Inter Info	[74], [46], [75]
D1731		Ethionamide	C8H10N2S	2761171	Moderate		Inter Info	[74], [46], [75]
D0066		Amiodarone	C25H29I2NO3	2157	Moderate		Inter Info	[74], [46], [75]
D0120		Atorvastatin	C33H35FN2O5	60823	Moderate		Inter Info	[74], [46], [75]
D0126		Auranofin	C20H34AuO9PS	24199313	Moderate		Inter Info	[74], [46], [75]
D0127		Aurothioglucose	C6H11AuO5S	454937	Moderate		Inter Info	[74], [46], [75]
D0162		Benznidazole	C12H12N4O3	31593	Moderate		Inter Info	[74], [46], [75]
D0199		Brentuximab vedotin	NA	NA	Moderate		Inter Info	[74], [98], [99]
D0227		Cabazitaxel	C45H57NO14	9854073	Moderate		Inter Info	[74], [46], [75]
D0261		Carfilzomib	C40H57N5O7	11556711	Moderate		Inter Info	[74], [46], [75]
D0380		Colchicine	C22H25NO6	6167	Moderate		Inter Info	[74], [46], [75]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Moderate		Inter Info	[74], [46], [75]
D0483		Didanosine	C10H12N4O3	135398739	Moderate		Inter Info	[74], [46], [75]
D0496		Diiodohydroxyquinoline	C9H5I2NO	3728	Moderate		Inter Info	[74], [46], [75]
D0501		Dinutuximab	NA	NA	Moderate		Inter Info	[74], [46], [75]
D0509		Disulfiram	C10H20N2S4	3117	Moderate		Inter Info	[74], [46], [75]
D0511		Docetaxel	C43H53NO14	148124	Moderate		Inter Info	[74], [46], [75]
D0560		Elotuzumab	NA	NA	Moderate		Inter Info	[74], [46], [75]
D0571		Enfortumab vedotin	NA	NA	Moderate		Inter Info	[74], [46], [75]
D0594		Eribulin	C40H59NO11	11354606	Moderate		Inter Info	[74], [46], [75]
D0669		Fludarabine	C10H12FN5O4	657237	Moderate		Inter Info	[74], [46], [75]
D0686		Fluvastatin	C24H26FNO4	446155	Moderate		Inter Info	[74], [46], [75]
D0770		Hydralazine	C8H8N4	3637	Moderate		Inter Info	[74], [46], [75]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Moderate		Inter Info	[74], [46], [75]
D0841		Ipilimumab	NA	NA	Moderate		Inter Info	[74], [46], [75]
D0858		Isoniazid	C6H7N3O	3767	Moderate		Inter Info	[74], [46], [75]
D0873		Ixabepilone	C27H42N2O5S	6445540	Moderate		Inter Info	[74], [46], [75]
D0874		Ixazomib	C14H19BCl2N2O4	25183872	Moderate		Inter Info	[74], [46], [75]
D0918		Levodopa	C9H11NO4	6047	Moderate		Inter Info	[74], [46], [75]
D1051		Metronidazole	C6H9N3O3	4173	Moderate		Inter Info	[74], [46], [75]
D1113		Naxitamab	NA	NA	Moderate		Inter Info	[74], [46], [75]
D1118		Nelarabine	C11H15N5O5	3011155	Moderate		Inter Info	[74], [46], [75]
D1212		Paclitaxel	C47H51NO14	36314	Moderate		Inter Info	[74], [46], [75]
D1213		Paclitaxel (protein-bound)	C47H51NO14	36314	Moderate		Inter Info	[74], [46], [75]
D1301		Pitavastatin	C25H24FNO4	5282452	Moderate		Inter Info	[74], [46], [75]
D1306		Polatuzumab vedotin	NA	NA	Moderate		Inter Info	[74], [46], [75]
D1312		Pomalidomide	C13H11N3O4	134780	Moderate		Inter Info	[74], [46], [75]
D1313		Ponatinib	C29H27F3N6O	24826799	Moderate		Inter Info	[74], [46], [75]
D1430		Rosuvastatin	C22H28FN3O6S	446157	Moderate		Inter Info	[74], [46], [75]
D1452		Secnidazole	C7H11N3O3	71815	Moderate		Inter Info	[74], [46], [75]
D1479		Sodium aurothiomalate	C4H3AuNa2O4S	22318	Moderate		Inter Info	[74], [46], [75]
D1543		Telbivudine	C10H14N2O5	159269	Moderate		Inter Info	[74], [46], [75]
D1587		Tinidazole	C8H13N3O4S	5479	Moderate		Inter Info	[74], [46], [75]
D1599		Tocilizumab	NA	NA	Moderate		Inter Info	[74], [46], [75]
D1615		Trabectedin	C39H43N3O11S	108150	Moderate		Inter Info	[74], [46], [75]
D1623		Trastuzumab emtansine	NA	NA	Moderate		Inter Info	[74], [46], [75]
D1715		Zalcitabine	C9H13N3O3	24066	Moderate		Inter Info	[68], [205]
D0821		Interferon alfa-2a, Recombinant	NA	NA	Moderate		Inter Info	[74], [46], [75]
D0822		Interferon alfa-2b	C16H17Cl3I2N3NaO5S	71306834	Moderate		Inter Info	[74], [46], [75]
D0824		Interferon alfa-n1	NA	NA	Moderate		Inter Info	[74], [46], [75]
D0823		Interferon alfacon-1	NA	NA	Moderate		Inter Info	[74], [46], [75]
D0933		Linezolid	C16H20FN3O4	441401	Moderate		Inter Info	[74], [46], [75]
D0956		Lovastatin	C24H36O5	53232	Moderate		Inter Info	[74], [46], [75]
D1145		Nitrofurantoin	C8H6N4O5	6604200	Moderate		Inter Info	[74], [46], [75]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Moderate		Inter Info	[74], [46], [75]
D1237		Peginterferon alfa-2a	NA	NA	Moderate		Inter Info	[74], [46], [75]
D1238		Peginterferon alfa-2b	NA	NA	Moderate		Inter Info	[74], [46], [75]
D1329		Pravastatin	C23H36O7	54687	Moderate		Inter Info	[74], [46], [75]
D1473		Simvastatin	C25H38O5	54454	Moderate		Inter Info	[74], [46], [75]
D1504		Stavudine	C10H12N2O4	18283	Moderate		Inter Info	[74], [46], [75]
D1551		Teniposide	C32H32O13S	452548	Moderate		Inter Info	[74], [46], [75]
D1700		Vinorelbine	C45H54N4O8	5311497	Moderate		Inter Info	[74], [46], [75]
D1714		Zafirlukast	C31H33N3O6S	5717	Moderate		Inter Info	[74], [46], [75]
Pharmacodynamic antagonistic effects
	Antagonize the effect of vaccine/toxoid					Drug Num: 23
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1744		Bacillus calmette-guerin substrain tice live antigen	NA	NA	Major		Inter Info	[11], [12], [13]
D1839		Measles virus vaccine live attenuated	NA	NA	Major		Inter Info	[11], [12], [13]
D1849		Mumps virus strain B level jeryl lynn live antigen	NA	NA	Major		Inter Info	[11], [12], [13]
D1881		Rotavirus vaccine	NA	NA	Major		Inter Info	[11], [12], [13]
D1882		Rubella virus vaccine	NA	NA	Major		Inter Info	[11], [12], [13]
D1890		Smallpox (Vaccinia) Vaccine, Live	NA	NA	Major		Inter Info	[24], [14], [25]
D1897		Talimogene laherparepvec	NA	NA	Major		Inter Info	[26]
D1914		Typhoid vaccine (live)	NA	NA	Major		Inter Info	[11], [12], [13]
D1920		Varicella Zoster Vaccine (Recombinant)	NA	NA	Major		Inter Info	[11], [12], [13]
D1922		Yellow Fever Vaccine	NA	NA	Major		Inter Info	[11], [12], [13]
D0089		Anthrax vaccine	NA	NA	Moderate		Inter Info	[24], [91], [92]
D0366		Clostridium tetani toxoid antigen (formaldehyde inactivated)	NA	NA	Moderate		Inter Info	[24], [91], [92]
D0755		Hepatitis A Vaccine	NA	NA	Moderate		Inter Info	[24], [91], [92]
D0756		Hepatitis B Vaccine (Recombinant)	NA	NA	Moderate		Inter Info	[24], [91], [92]
D0767		Human papillomavirus type 11 L1 capsid protein antigen	NA	NA	Moderate		Inter Info	[24], [91], [92]
D0803		Influenza A virus A/California/7/2009 (H1N1)-like antigen (propiolactone inactivated)	NA	NA	Moderate		Inter Info	[24], [91], [92]
D0804		Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated)	NA	NA	Moderate		Inter Info	[24], [91], [92]
D0999		Meningococcal polysaccharide vaccine group C	NA	NA	Moderate		Inter Info	[24], [91], [92]
D1259		Pfizer-BioNTech Covid-19 Vaccine	NA	NA	Moderate		Inter Info	[160], [24], [14], [161], [162], [163], [91], [164], [165], [166], [92]
D1307		Poliovirus type 1 antigen (formaldehyde inactivated)	NA	NA	Moderate		Inter Info	[24], [91], [92]
D1662		Typhoid vaccine (inactivated)	NA	NA	Moderate		Inter Info	[24], [91], [92]
D1692		Vibrio cholerae CVD 103-HgR strain live antigen	NA	NA	Moderate		Inter Info	[24], [91], [92]
D1838		Lyme disease vaccine (recombinant OspA)	NA	NA	Moderate		Inter Info	[233]
	Antagonize the effect of probiotics					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1749		Bifidobacterium longum infantis	NA	NA	Moderate		Inter Info	[94], [95], [96]
D1827		Lactobacillus acidophilus	NA	NA	Moderate		Inter Info	[94], [95], [96]
	Diminish the response to diagnostic skin test antigens					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1755		Candida albicans	C29H27N2O12P	118855431	Moderate		Inter Info	[101], [102], [103]
D1765		Coccidioides immitis spherule	NA	NA	Moderate		Inter Info	[101], [102], [103]
D1912		Trichophyton mentagrophytes	NA	NA	Moderate		Inter Info	[101], [102], [103]
D1913		Tuberculin purified protein derivative	NA	NA	Moderate		Inter Info	[101], [102], [103]
	Attenuated pharmacological effects (Unspecific)					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0659		Filgrastim	NA	NA	Moderate		Inter Info	[206], [207], [208]
D1235		Pegfilgrastim	C27H46N4O19	70683024	Moderate		Inter Info	[238], [239]
D1446		Sargramostim	NA	NA	Moderate		Inter Info	[206], [207], [208]

References
1	Product Information. Cimzia (certolizumab). UCB Pharma Inc, Smyrna, GA.
2	Product Information. Enbrel (etanercept). Wyeth-Ayerst Laboratories, Philadelphia, PA.
3	Product Information. Humira (adalimumab). Abbott Pharmaceutical, Abbott Park, IL.
4	Product Information. Remicade (infliximab). Centocor Inc, Malvern, PA.
5	Product Information. Simponi (golimumab). Centocor Inc, Malvern, PA.
6	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Drug labels for the Tumor Necrosis Factor-alpha (TNFa) blockers now include warnings about infection with Legionella and Listeria bacteria. ".
7	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
8	Product Information. Leustatin (cladribine). Ortho Biotech Inc, Raritan, NJ.
9	Product Information. Clozaril (clozapine). Novartis Pharmaceuticals, East Hanover, NJ.
10	Canadian Pharmacists Association "e-CPS."
11	Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, eds. "Harrison's Principles of Internal Medicine. 14th ed." New York, NY: McGraw-Hill Health Professionals Division (1998).
12	Product Information. Attenuvax (measles virus vaccine, live, attenuated). Merck &amp Co, Inc, West Point, PA.
13	Product Information. YF-Vax (yellow fever vaccine). sanofi pasteur, Swiftwater, PA.
14	Cerner Multum, Inc. "Australian Product Information.".
15	Product Information. Olumiant (baricitinib). Lilly, Eli and Company, Indianapolis, IN.
16	Product Information. Ferriprox (deferiprone). ApoPharma USA Inc, Rockville, MD.
17	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports."
18	Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
19	Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
20	Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
21	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
22	Product Information. Quadramet (samarium sm 153 lexidronam) Berlex Laboratories, Richmond, CA.
23	Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
24	CDC. Centers for Disease Control and Prevention/ "Recommendations of the advisory committtee on immunization practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence." MMWR Morb Mortal Wkly Rep 42(RR-04) (1993): 1-18. [PMID: 20300058]
25	Product Information. Dryvax (smallpox vaccine). Wyeth-Ayerst Laboratories, Philadelphia, PA.
26	Product Information. Imlygic (talimogene laherparepvec). Amgen USA, Thousand Oaks, CA.
27	Bennett CL, Nebeker JR, Samore MH, et al "The Research on Adverse Drug Events and Reports (RADAR) project." JAMA 293 (2005): 2131-40. [PMID: 15870417]
28	Bennett CL, Schumock GT, Desai AA, et al "Thalidomide-associated deep vein thrombosis and pulmonary embolism." Am J Med 113 (2002): 603-6. [PMID: 12459408]
29	Cavo M, Zamagni E, Cellini C, et al. "Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy." Blood 100 (2002): 2272-3. [PMID: 12229885]
30	Escudier B, Lassau N, Leborgne S, Angevin E, Laplanche A "Thalidomide and venous thrombosis." Ann Intern Med 136 (2002): 711. [PMID: 11992318]
31	Figg WD, Arlen P, Gulley J, et al. "A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancer." Semin Oncol 28(4 Suppl 15) (2001): 62-6. [PMID: 11685731]
32	Fine HA, Wen PY, Maher EA, et al. "Phase II Trial of Thalidomide and Carmustine for Patients With Recurrent High-Grade Gliomas." J Clin Oncol 21 (2003): 2299-304. [PMID: 12805330]
33	Lee CK, Barlogie B, Munshi N, et al "DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma." J Clin Oncol 21 (2003): 2732-9. [PMID: 12860952]
34	Osman K, Comenzo R, Rajkumar SV "Deep venous thrombosis and thalidomide therapy for multiple myeloma." N Engl J Med 344 (2001): 1951-2. [PMID: 11419443]
35	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
36	Rajkumar SV, Hayman S, Gertz MA, et al. "Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma." J Clin Oncol 20 (2002): 4319-23. [PMID: 12409330]
37	Urbauer E, Kaufmann H, Nosslinger T, Raderer M, Drach J "Thromboembolic events during treatment with thalidomide." Blood 99 (2002): 4247-8. [PMID: 12043695]
38	Weber D, Rankin K, Gavino M, Delasalle K, Alexanian R "Thalidomide alone or with dexamethasone for previously untreated multiple myeloma." J Clin Oncol 21 (2003): 16-9. [PMID: 12506164]
39	Zangari M, Anaissie E, Barlogie B, et al "Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy." Blood 98 (2001): 1614-5. [PMID: 11520815]
40	Zangari M, Barlogie B, Anaissie E, et al "Deep vein thrombosis in patients with mutiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation." Br J Haematol 126 (2004): 715-21. [PMID: 15327525]
41	Zangari M, Siegel E, Barlogie B, et al "Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy." Blood 100 (2002): 1168-71. [PMID: 12149193]
42	Desai AA, Vogelzang NJ, Rini BI, Ansari R, Krauss S, Stadler WM "A high rate of venous thromboembolism in a multi-institutional Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma." Cancer 95 (2002): 1629-36. [PMID: 12365009]
43	Product Information. Xeljanz (tofacitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
44	Product Information. Rinvoq (upadacitinib). AbbVie US LLC, North Chicago, IL.
45	Product Information. Tysabri (natalizumab). Elan Pharmaceutical/Athena Neurosciences Inc, South San Francisco, CA.
46	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
47	Product Information. Fluorouracil injection (fluorouracil). Roche Laboratories, Nutley, NJ.
48	Product Information. Amevive (alefacept). Biogen, Cambridge, MA.
49	Product Information. Lonsurf (tipiracil-trifluridine). Taiho Oncology, Inc., Princeton, NJ.
50	Product Information. Campath (alemtuzumab) Berlex, Richmond, CA.
51	Product Information. Arcalyst (rilonacept). Regeneron Pharmaceuticals Inc, Tarrytown, NY.
52	Product Information. Ilaris (canakinumab). Novartis Pharmaceuticals, East Hanover, NJ.
53	Product Information. Kineret (anakinra). Amgen, Thousand Oaks, CA.
54	Charasson V, Haaz MC, Robert J "Determination of Drug Interactions Occurring with the Metabolic Pathways of Irinotecan." Drug Metab Dispos 30 (2002): 731-733. [PMID: 12019202]
55	Clarke SJ, Rivory LP "Clinical pharmacokinetics of docetaxel." Clin Pharmacokinet 36 (1999): 99-114. [PMID: 10092957]
56	Kivisto KT, Kroemer HK, Eichelbaum M "The role of human cytochrome p450 enzymes in the metabolism of anticancer agents: implications for drug interactions." Br J Clin Pharmacol 40 (1995): 523-30. [PMID: 8703657]
57	Product Information. Emend (aprepitant). Merck & Company Inc, West Point, PA.
58	Product Information. Emend for Injection (fosaprepitant). Merck & Company Inc, West Point, PA.
59	Zhou XJ, Zhou-Pan XR, Gauthier T, Placidi M, Maurel P, Rahmani R "Human liver microsomal cytochrome P450 3A isozymes mediated vindesine biotransformation. Metabolic drug interactions." Biochem Pharmacol 45 (1993): 853-61. [PMID: 8452560]
60	Product Information. Targretin (bexarotene) Ligand Pharmaceuticals, San Diego, CA.
61	Wakelee HA, Takimoto CH, Lopez-Anaya A, et al. "The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer." Cancer Chemother Pharmacol 69 (2012): 563-71. [PMID: 22057855]
62	Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".
63	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
64	Product Information. Ellence (epirubicin) Pharmacia and Upjohn, Kalamazoo, MI.
65	Product Information. Ifex (ifosfamide). Bristol-Myers Squibb, Princeton, NJ.
66	Product Information. Paraplatin (carboplatin). Bristol-Myers Squibb, Princeton, NJ.
67	Product Information. Zanosar (streptozocin). Pharmacia and Upjohn, Kalamazoo, MI.
68	Argov Z, Mastaglia FL "Drug-induced peripheral neuropathies." Br Med J 1 (1979): 663-6. [PMID: 219931]
69	Cavaletti G, Jakubowiak AJ "Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies." Leuk Lymphoma 51 (2010): 1178-87. [PMID: 20497001]
70	Product Information. Velcade (bortezomib). Millennium Pharmaceuticals Inc, Cambridge, MA.
71	Product Information. Tracleer (bosentan). Acetelion Pharmaceuticals US, Inc, South San Francisco, CA.
72	Rodman JH, Murry DJ, Madden T, Santana VM "Altered etoposide pharmacokinetics and time to engraftment in pediatric patients undergoing autologous bone marrow transplantation." J Clin Oncol 12 (1994): 2390-7. [PMID: 7964955]
73	Rodman JH, Murry DJ, Madden T, Santana VM "Pharmacokinetics of high doses of etoposide and the influence of anticonvulsants in pediatric cancer patients." Clin Pharmacol Ther 51 (1992): 156. [PMID: 1611808]
74	Carrion C, Espinosa E, Herrero A, Garcia B "Possible vincristine-isoniazid interaction." Ann Pharmacother 29 (1995): 201. [PMID: 7756727]
75	Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online."
76	Bisogno G, Cowie F, Boddy A, Thomas HD, Dick G, Pinkerton CR "High-dose cyclosporin with etoposide--toxicity and pharmacokinetic interaction in children with solid tumours." Br J Cancer 77 (1998): 2304-9. [PMID: 9649150]
77	Lum BL, Kaubisch S, Yahanda AM, Adler KM, Jew L, Ehsan MN, Brophy NA, Halsey J, Gosland MP, Sikic BI "Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance." J Clin Oncol 10 (1992): 1635-42. [PMID: 1403041]
78	Guo LQ, Yamazoe Y "Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines." Acta Pharmacol Sin 25 (2004): 129-36. [PMID: 14769198]
79	Le AT, Hasson NK, Lum BL "Enhancement of warfarin response in a patient receiving etoposide and carboplatin chemotherapy." Ann Pharmacother 31 (1997): 1006-8. [PMID: 9296241]
80	Seifter EJ, Brooks BJ, Urba WJ "Possible interactions between warfarin and antineoplastic drugs." Cancer Treat Rep 69 (1985): 244-5. [PMID: 3971397]
81	Abernethy DR, Egan JM, Dickinson TH, Carrum G "Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans." J Pharmacol Exp Ther 244 (1988): 994-9. [PMID: 3252045]
82	Renton KW "Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil." Biochem Pharmacol 34 (1985): 2549-53. [PMID: 4015695]
83	Sakai H, Kobayashi S, Hamada K, et al "The effects of diltiazem on hepatic drug metabolizing enzymes in man using antipyrine, trimethadione and debrisoquine as model substrates." Br J Clin Pharmacol 31 (1991): 353-5. [PMID: 2054276]
84	Sutton D, Butler AM, Nadin L, Murray M "Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites." J Pharmacol Exp Ther 282 (1997): 294-300. [PMID: 9223567]
85	Varis T, Backman JT, Kivisto KT, Neuvonen PJ "Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisolone." Clin Pharmacol Ther 67 (2000): 215-21. [PMID: 10741623]
86	Product Information. Raptiva (efalizumab). Genentech, South San Francisco, CA.
87	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
88	Product Information. Xeglyze (abametapir topical). Dr. Reddy's Laboratories Inc, Upper Saddle River, NJ.
89	Product Information. Diovan (valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
90	Product Information. Piqray (alpelisib). Novartis Pharmaceuticals, East Hanover, NJ.
91	Product Information. Imovax Rabies (rabies vaccine). sanofi pasteur, Swiftwater, PA.
92	Department of Health. National Health Service "Immunisation Against Infectious Disease - "The Green Book". Chapter 6: Contraindications and special considerations.".
93	Product Information. Erleada (apalutamide). Janssen Biotech, Inc., Horsham, PA, PA.
94	Borriello SP, Hammes WP, Holzapfel W, et.al "Safety of probiotics that contain lactobacilli or bifidobacteria." Clin Infect Dis 36 (2003): 775-80. [PMID: 12627362]
95	Schlegel L, Lemerle S, Geslin P "Lactobacillus species as opportunistic pathogens in immunocompromised patients." Eur J Clin Microbiol Infect Dis 17 (1998): 887-8. [PMID: 10052559]
96	Salminen MK, Tynkkynen S, Rautelin H, et al. "Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland." Clin Infect Dis 35 (2002): 1155-60. [PMID: 12410474]
97	Product Information. Victrelis (boceprevir). Schering-Plough Corporation, Kenilworth, NJ.
98	Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
99	Product Information. Danyelza (naxitamab). Y-mAbs Therapeutics, New York, NY.
100	Product Information. Alunbrig (brigatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
101	Product Information. Tuberculin PPD (Mantoux) (tuberculin purified protein derivative). Connaught Laboratories Ltd, Toronto, ON.
102	Product Information. Candin (candida albicans extract). Nielsen Biosciences Inc, San Diego, CA.
103	Product Information. Spherulin (coccidioidin skin test). ALK Laboratories Inc, Wallingford, CT.
104	Product Information. Tabrecta (capmatinib). Novartis Pharmaceuticals, East Hanover, NJ.
105	Product Information. Xcopri (cenobamate). SK Life Science, Inc., Paramus, NJ.
106	Product Information. Zykadia (ceritinib). Novartis Pharmaceuticals, East Hanover, NJ.
107	Product Information. Vaprisol (conivaptan). Cumberland Pharmaceuticals Inc, Nashville, TN.
108	Product Information. Tafinlar (dabrafenib). GlaxoSmithKline, Research Triangle Park, NC.
109	Product Information. Daklinza (daclatasvir). Bristol-Myers Squibb, Princeton, NJ.
110	Product Information. Synercid (dalfopristin-quinupristin) Rhone-Poulenc Rorer, Collegeville, PA.
111	Product Information. Prezista (darunavir). Ortho Biotech Inc, Bridgewater, NJ.
112	Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.
113	Product Information. Exjade (deferasirox). Novartis Pharmaceuticals, East Hanover, NJ.
114	Skerjanec A, Wang J, Maren K, Rojkjaer L "Investigation of the pharmacokinetic interactions of deferasirox, a once-daily oral iron chelator, with midazolam, rifampin, and repaglinide in healthy volunteers." J Clin Pharmacol 50 (2010): 205-13. [PMID: 19940232]
115	Product Information. Prolia (denosumab). Amgen USA, Thousand Oaks, CA.
116	Product Information. Vumerity (diroximel fumarate). Alkermes, Inc, Cambridge, MA.
117	Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
118	Product Information. Copiktra (duvelisib). Verastem, Inc., Needham, MA.
119	Gorski JC, Huang SM, Pinto A, et al. "The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo." Clin Pharmacol Ther 75 (2004): 89-100. [PMID: 14749695]
120	Product Information. Braftovi (encorafenib). Array BioPharma Inc., Boulder, CO.
121	Benoist G, van Oort I, et al "Drug-drug interaction potential in men treated with enzalutamide: Mind the gap." Br J Clin Pharmacol 0 (2017): epub. [PMID: 28881501]
122	Product Information. Xtandi (enzalutamide). Astellas Pharma US, Inc, Deerfield, IL.
123	Product Information. Balversa (erdafitinib). Janssen Products, LP, Horsham, PA.
124	Product Information. Intelence (etravirine). Ortho Biotech Inc, Bridgewater, NJ.
125	Product Information. Inrebic (fedratinib). Celgene Corporation, Summit, NJ.
126	Product Information. Akynzeo (netupitant-palonosetron). Eisai Inc, Woodcliff Lake, NJ.
127	Product Information. Akynzeo for Injection (fosnetupitant-palonosetron). Helsinn Therapeutics Inc, Woodbridge Township, NJ.
128	Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.
129	Product Information. Cytovene (ganciclovir). Genentech, South San Francisco, CA.
130	Product Information. Valcyte (valganciclovir) Roche Laboratories, Nutley, NJ.
131	Product Information. Xospata (gilteritinib). Astellas Pharma US, Inc, Deerfield, IL.
132	Product Information. Daurismo (glasdegib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
133	Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
134	Product Information. Cresemba (isavuconazonium). Astellas Pharma US, Inc, Deerfield, IL.
135	Auclair B, Berning SE, Huitt GA, Peloquin CP "Potential interaction between itraconazole and clarithromycin." Pharmacotherapy 19 (1999): 1439-44. [PMID: 10600094]
136	Chiba M, Hensleigh M, Nishime JA, Balani SK, Lin JH "Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor." Drug Metab Dispos 24 (1996): 307-14. [PMID: 8820421]
137	Gillies J, Hung KA, Fitzsimons E, Soutar R "Severe vincristine toxicity in combination with itraconazole." Clin Lab Haematol 20 (1998): 123-4. [PMID: 9681224]
138	Kaukonen KM, Olkkola KT, Neuvonen PJ "Itraconazole increases plasma concentrations of quinidine." Clin Pharmacol Ther 62 (1997): 510-7. [PMID: 9390107]
139	Lukkari E, Juhakoski A, Aranko K, Neuvonen PJ "Itraconazole moderately increases serum concentrations of oxybutynin but does not affect those of the active metabolite." Eur J Clin Pharmacol 52 (1997): 403-6. [PMID: 9272412]
140	Product Information. Sporanox (itraconazole). Janssen Pharmaceutica, Titusville, NJ.
141	Tailor SAN "Peripheral edema due to nifedipine-itraconazole interaction: a case report." Arch Dermatol 132 (1996): 1374. [PMID: 8607648]
142	Varis T, Kaukonen KM, Kivisto KT, Neuvonen PJ "Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole." Clin Pharmacol Ther 64 (1998): 363-8. [PMID: 9797792]
143	Product Information. Kalydeco (ivacaftor). Vertex Pharmaceuticals, Cambridge, MA.
144	Product Information. Tykerb (lapatinib). Novartis Pharmaceuticals, East Hanover, NJ.
145	Product Information. Vitrakvi (larotrectinib). Bayer Pharmaceutical Inc, West Haven, CT.
146	Product Information. Reyvow (lasmiditan). Lilly, Eli and Company, Indianapolis, IN.
147	Product Information. Harvoni (ledipasvir-sofosbuvir). Gilead Sciences, Foster City, CA.
148	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
149	Product Information. Prevymis (letermovir). Merck & Company Inc, Whitehouse Station, NJ.
150	Product Information. Zokinvy (lonafarnib). Eiger BioPharmaceuticals, Palo Alto, CA.
151	Product Information. Lorbrena (lorlatinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
152	He K, Woolf TF, Hollenberg PF "Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486)." J Pharmacol Exp Ther 288 (1999): 791-7. [PMID: 9918590]
153	Product Information. Mifeprex (mifepristone) Danco Laboratories, New York, NY.
154	Product Information. Serzone (nefazodone). Bristol-Myers Squibb, Princeton, NJ.
155	Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
156	Product Information. Zejula (niraparib). Tesaro Inc., Waltham, MA.
157	Product Information. Ocrevus (ocrelizumab). Genentech, South San Francisco, CA.
158	Product Information. Lynparza (olaparib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
159	Product Information. Synribo (omacetaxine). Teva Pharmaceuticals USA, North Wales, PA.
160	CDC Centers for Disease Control and Prevention "General Best Practice Guidelines for Immunization: Altered Immunocompetence." .
161	Product Information. Biothrax (anthrax vaccine adsorbed). Emergent BioSolutions Inc., Lansing, MI.
162	Product Information. Fluzone Influenza Vaccine (influenza virus vaccine). Connaught, Swiftwater, PA.
163	Product Information. Havrix (hepatitis A vaccine). SmithKline Beecham, Philadelphia, PA.
164	Product Information. Influenza Virus Vaccine, H5N1, Inactivated (influenza virus vaccine, H5N1, inactivated). GlaxoSmithKline, Research Triangle Park, NC.
165	Product Information. Omnihib (haemophilus b conjugate vaccine). SmithKline Beecham, Philadelphia, PA.
166	CDC Centers for Disease Control and Prevention "Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States.".
167	Product Information. Wakix (pitolisant). Harmony Biosciences, LLC, Plymouth Meeting, PA.
168	Product Information. Xofigo (radium Ra 223 dichloride). Bayer Pharmaceutical Inc, West Haven, CT.
169	DSouza DL, Levasseur LM, Nezamis J, Robbins DK, Simms L, Koch KM "Effect of alosetron on the pharmacokinetics of alprazolam." J Clin Pharmacol 41 (2001): 452-4. [PMID: 11304902]
170	Kane GC, Lipsky JJ "Drug-grapefruit juice interactions." Mayo Clin Proc 75 (2000): 933-42. [PMID: 10994829]
171	Katoh M, Nakajima M, Yamazaki H, Yokoi T "Inhibitory effects of CYP3A4 substrates and their metabolites on P-glycoprotein-mediated transport." Eur J Pharm Sci 12 (2001): 505-13. [PMID: 11231118]
172	Nagy J, Schipper HG, Koopmans RP, Butter JJ, van Boxtel CJ, Kager PA "Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability." Am J Trop Med Hyg 66 (2002): 260-3. [PMID: 12139218]
173	Product Information. Kisqali (ribociclib). Novartis Pharmaceuticals, East Hanover, NJ.
174	Rawden HC, Kokwaro GO, Ward SA, Edwards G "Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes." Br J Clin Pharmacol 49 (2000): 313-22. [PMID: 10759686]
175	Trivier JM, Libersa C, Belloc C, Lhermitte M "Amiodarone N-deethylation in human liver microsomes: involvement of cytochrome P450 3A enzymes (first report)." Life Sci 52 (1993): pl91-6. [PMID: 8445979]
176	Yu DK "The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions." J Clin Pharmacol 39 (1999): 1203-11. [PMID: 10586385]
177	Product Information. Priftin (rifapentine). Hoechst Marion-Roussel Inc, Kansas City, MO.
178	Thijssen HH, Flin ois JP, Beaune PH "Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes." Drug Metab Dispos 28 (2000): 1284-90. [PMID: 11038154]
179	Product Information. Daxas (roflumilast). Nycomed Inc, Princeton, NJ.
180	Product Information. Varubi (rolapitant). Tesaro Inc., Waltham, MA.
181	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
182	Product Information. Banzel (rufinamide). Eisai Inc, Teaneck, NJ.
183	Product Information. Fortovase (saquinavir) Roche Laboratories, Nutley, NJ.
184	Product Information. Invirase (saquinavir). Roche Laboratories, Nutley, NJ.
185	Product Information. Retevmo (selpercatinib). Lilly, Eli and Company, Indianapolis, IN.
186	Product Information. Prograf (tacrolimus). Fujisawa, Deerfield, IL.
187	Product Information. Rapamune (sirolimus) Wyeth-Ayerst Laboratories, Philadelphia, PA.
188	AnazaoHealth Corporation "P32 Sodium Phosphate."
189	Product Information. Zorbtive (somatropin). Serono Laboratories Inc, Rockland, MA.
190	Product Information. Humatrope (somatropin). Lilly, Eli and Company, Indianapolis, IN.
191	Roby CA, Anderson GD, Kantor E, Dryer DA, Burstein AH "St John's Wort: Effect on CYP3A4 activity." Clin Pharmacol Ther 67 (2000): 451-7. [PMID: 10824623]
192	Sparreboom A, Cox MC, Acharya MR, Figg WD "Herbal remedies in the United States: potential adverse interactions with anticancer agents." J Clin Oncol 22 (2004): 2489-503. [PMID: 15197212]
193	Multum Information Services, Inc. Expert Review Panel.
194	Product Information. Tazverik (tazemetostat). Epizyme, Inc, Cambridge, MA.
195	Product Information. Incivek (telaprevir). Vertex Pharmaceuticals, Cambridge, MA.
196	Product Information. Ketek (telithromycin). Aventis Pharmaceuticals, Bridgewater, NJ.
197	European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products "European Public Assessment Report Ketek (telithromycin) (Rev. 2) ".
198	Product Information. Xermelo (telotristat ethyl). Lexicon Pharmaceuticals, Inc., The Woodlands, TX.
199	Product Information. Jynarque (tolvaptan). Otsuka American Pharmaceuticals Inc, Rockville, MD.
200	Product Information. Samsca (tolvaptan). Otsuka American Pharmaceuticals Inc, Rockville, MD.
201	Product Information. Hycamtin (topotecan). SmithKline Beecham, Philadelphia, PA.
202	Product Information. Tukysa (tucatinib). Seattle Genetics Inc, Bothell, WA.
203	Product Information. Stelara (ustekinumab). Centocor Inc, Malvern, PA.
204	Product Information. Oxbryta (voxelotor). Global Blood Therapeutics, Inc., South San Francisco, CA.
205	Product Information. Hivid (zalcitabine). Roche Laboratories, Nutley, NJ.
206	Product Information. Granix (tbo-filgrastim). Teva Pharmaceuticals USA, North Wales, PA.
207	Product Information. Leukine (sargramostim). Immunex Corporation, Seattle, WA.
208	Product Information. Stemgen (ancestim) Amgen, Thousand Oaks, CA.
209	Assan R, Fredj G, Larger E, Feutren G, Bismuth H "FK 506/fluconazole interaction enhances FK 506 nephrotoxicity." Diabete Metab 20 (1994): 49-52. [PMID: 7520007]
210	Baciewicz AM, Baciewicz FA, Jr "Ketoconazole and fluconazole drug interactions." Arch Intern Med 153 (1993): 1970-6. [PMID: 8357281]
211	Barbara JA, Clarkson AR, LaBrooy J, et al "Candida albicans arthritis in a renal allograft recipient with an interaction between cyclosporin and fluconazole." Nephrol Dial Transplant 8 (1993): 263-6. [PMID: 8385297]
212	Bedford TA, Rowbotham DJ "Cisapride: drug interactions of clinical significance." Drug Saf 15 (1996): 167-75. [PMID: 8879971]
213	Canafax DM, Graves NM, Hilligoss DM, et al "Interaction between cyclosporine and fluconazole in renal allograft recipients." Transplantation 51 (1991): 1014-8. [PMID: 2031258]
214	Dresser GK, Spence JD, Bailey DG "Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition." Clin Pharmacokinet 38 (2000): 41-57. [PMID: 10668858]
215	Finch CK, Green CA, Self TH "Fluconazole-carbamazepine interaction." South Med J 95 (2002): 1099-100. [PMID: 12356123]
216	Hilbert J, Messig M, Kuye O, Friedman H "Evaluation of interaction between fluconazole and an oral contraceptive in healthy women." Obstet Gynecol 98 (2001): 218-23. [PMID: 11506836]
217	Lopez-Gil JA "Fluconazole-cyclosporin interaction: a dose-dependent effect?" Ann Pharmacother 27 (1993): 427-30. [PMID: 8477116]
218	Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75. [PMID: 10926350]
219	Nair DR, Morris HH "Potential fluconazole-induced carbamazepine toxicity." Ann Pharmacother 33 (1999): 790-2. [PMID: 10466905]
220	Osowski CL, Dix SP, Lin LS, Mullins RE, Geller RB, Wingard JR "Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients." Transplantation 61 (1996): 1268-72. [PMID: 8610430]
221	Product Information. Diflucan (fluconazole). Roerig Division, New York, NY.
222	Sinofsky FE, Pasquale SA "The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives." Am J Obstet Gynecol 178 (1998): 300-4. [PMID: 9500490]
223	Sugar AM, Saunders C, Idelson BA, Bernard DB "Interaction of fluconazole and cyclosporine." Ann Intern Med 110 (1989): 844. [PMID: 2540690]
224	Torregrosa V, De la Torre M, Campistol JM, et al "Interaction of fluconazole with ciclosporin A." Nephron 60 (1992): 125-6. [PMID: 1738408]
225	Tsouli S, Maranis S, Kyritsis AP "Fluconazole-carbamazepine interaction in a patient with bipolar disorder." Psychiatry Clin Neurosci 65 (2011): 112. [PMID: 21265947]
226	Ulivelli M, Rubegni P, Nuti D, Bartalini S, Giannini F, Rossi S "Clinical evidence of fluconazole-induced carbamazepine toxicity." J Neurol 251 (2004): 622-3. [PMID: 15164201]
227	Damkier P, Hansen LL, Brosen K "Effect of fluvoxamine on the pharmacokinetics of quinidine." Eur J Clin Pharmacol 55 (1999): 451-6. [PMID: 10492058]
228	Product Information. Luvox (fluvoxamine). Solvay Pharmaceuticals Inc, Marietta, GA.
229	Product Information. Multihance (gadobenate dimeglumine). Bracco Diagnostics Inc, Princeton, NJ.
230	Huisman MT, Smit JW, Crommentuyn KM, et al. "Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs." AIDS 16 (2002): 2295-2301. [PMID: 12441801]
231	Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
232	Product Information. Gleevec (imatinib mesylate). Novartis Pharmaceuticals, East Hanover, NJ.
233	Shen AK, Mead PS, Beard CB. The Lyme disease vaccine--a public health perspective. Clin Infect Dis. 2011;52 Suppl 3:s247-s252. [PMID: 21217171]
234	Product Information. Viracept (nelfinavir). Agouron Pharma Inc, La Jolla, CA.
235	Product Information. Viramune (nevirapine). Boehringer-Ingelheim, Ridgefield, CT.
236	Product Information. Viramune XR (nevirapine). Boehringer Ingelheim, Ridgefield, CT.
237	Product Information. Kepivance (palifermin). Shire US Inc, Florence, KY.
238	Product Information. Brukinsa (zanubrutinib). BeiGene USA, Inc, San Mateo, CA.
239	Product Information. Neulasta (pegfilgrastim). Amgen, Thousand Oaks, CA.
240	Olkkola KT, Palkama VJ, Neuvonen PJ "Ritonavir's role in reducing fentanyl clearance and prolonging its half-life." Anesthesiology 91 (1999): 681-5. [PMID: 10485779]
241	Product Information. Norvir (ritonavir). Abbott Pharmaceutical, Abbott Park, IL.
242	Product Information. VFEND (voriconazole). Pfizer U.S. Pharmaceuticals, New York, NY.
243	Product Information. Retrovir (zidovudine). Glaxo Wellcome, Research Triangle Park, NC.
244	Johnson EJ, MacGowan AP, Potter MN, et al "Reduced absorption of oral ciprofloxacin after chemotherapy for haematological malignancy." J Antimicrob Chemother 25 (1990): 837-42. [PMID: 2373666]
245	Barry M, Mulcahy F, Merry C, Gibbons S, Back D "Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection." Clin Pharmacokinet 36 (1999): 289-304. [PMID: 10320951]
246	Cheng CL, Smith DE, Carver PL, Cox SR, Watkins PB, Blake DS, Kauffman CA, Meyer KM, Amidon GL, Stetson PL "Steady-state pharmacokinetics of delavirdine in HIV-positive patients: Effect on erythromycin breath test." Clin Pharmacol Ther 61 (1997): 531-43. [PMID: 9164415]
247	Fichtenbaum CJ, Gerber JG "Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection." Clin Pharmacokinet 41 (2002): 1195-211. [PMID: 12405866]
248	Product Information. Rescriptor (delavirdine). Pharmacia and Upjohn, Kalamazoo, MI.
249	vonMoltke LL, Greenblatt DJ, Granda BW, Giancarlo GM, Duan SX, Daily JP, Harmatz JS, Shader RI "Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitors." J Clin Pharmacol 41 (2001): 85-91. [PMID: 11225565]
250	Voorman RL, Maio SM, Payne NA, Zhao Z, Koeplinger KA, Wang X "Microsomal metabolism of delavirdine: evidence for mechanism-based inactivation of human cytochrome P450 3A." J Pharmacol Exp Ther 287 (1998): 381-8. [PMID: 9765359]
251	Doherty MM, Charman WN "The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?" Clin Pharmacokinet 41 (2002): 235-53. [PMID: 11978143]
252	Product Information. Nuvigil (armodafinil). Cephalon Inc, West Chester, PA.
253	Product Information. Provigil (modafinil). Cephalon, Inc, West Chester, PA.
254	Robertson P Jr, Hellriegel ET, Arora S, Nelson M "Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers." Clin Pharmacol Ther 71 (2002): 46-56. [PMID: 11823757]
255	Robertson P, Decory HH, Madan A, Parkinson A "In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil." Drug Metab Dispos 28 (2000): 664-71. [PMID: 10820139]
256	Cummings J, Forrest GJ, Cunningham D, Gilchrist NL, Soukop M "Influence of polysorbate 80 (tween 80) and etoposide (VP-16-213 on the pharmacokinetics and urinary excretion of adriamycin and its metabolites in cancer patients." Cancer Chemother Pharmacol 17 (1987): 80-4. [PMID: 3698181]
257	Sacristan JA, Kennedy-Martin T, Rosell R, Cardenal F, Anton A, Lomas M, Alberola V, Massuti B, Carrato A, Minshall M. Economic evaluation in a randomized phase III clinical trial comparing gemcitabine/cisplatin and etoposide/cisplatin in non-small cell lung cancer. Lung Cancer. 2000 May;28(2):97-107.
258	Zhou-Pan XR, Seree E, Zhou XJ, et al "Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions." Cancer Res 53 (1993): 5121-6. [PMID: 8221648]
259	Product Information. Oncovin (vincristine). Lilly, Eli and Company, Indianapolis, IN.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence